XOMA Royalty (XOMA) Interest Expenses (2010 - 2026)
XOMA Royalty (XOMA) reported Interest Expenses of $22.1 million for Q1 2026, up 245.42% on a YoY basis from $6.4 million in Q1 2025, and up 40.67% sequentially from $15.7 million in Q2 2025.
XOMA Royalty (XOMA) Interest Expenses (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Interest Expenses data on file, last reported at $22.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 245.42% year-over-year to $22.1 million; the trailing twelve-month figure through Mar 2026 stood at $22.1 million (up 58.04% YoY), and the FY2025 full-year result was $159.9 million, up 87.8% from the prior year.
- Interest Expenses improved to $22.1 million in Q1 2026, from $15.7 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $22.1 million in Q1 2026 to a low of $50000.0 in Q1 2022.
- A 5-year average of $9.0 million and a median of $6.8 million in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses sank 82.7% in 2022 and surged 1694.0% in 2023, its largest moves.
- Tracing XOMA's Interest Expenses over 5 years: stood at $51000.0 in 2022, then jumped by 711.76% to $414000.0 in 2023, then surged by 719.81% to $3.4 million in 2024, then soared by 363.02% to $15.7 million in 2025, then surged by 40.67% to $22.1 million in 2026.
- Business Quant data shows XOMA's Interest Expenses at $22.1 million in Q1 2026, $15.7 million in Q2 2025, and $6.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 22.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.11 Mn |
| Mar 31, 2026 | 22.11 Mn |
| Jun 30, 2025 | 15.72 Mn |
| Jun 30, 2025 | 15.72 Mn |
| Mar 31, 2025 | 6.40 Mn |
| Mar 31, 2025 | 6.40 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Sep 30, 2024 | 20.22 Mn |
| Sep 30, 2024 | 20.22 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 3.78 Mn |
| Mar 31, 2024 | 3.78 Mn |
| Dec 31, 2023 | 414,000.00 |
| Dec 31, 2023 | 414,000.00 |
| Sep 30, 2023 | 6.80 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jun 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 11.43 Mn |